2FL5
Cofactor-containing antibodies: Crystal structure of the original yellow antibody
Summary for 2FL5
Entry DOI | 10.2210/pdb2fl5/pdb |
Descriptor | Immunoglobulin Igg1 Lambda Light Chain, Immunoglobulin Igg1 Heavy chain, RIBOFLAVIN, ... (4 entities in total) |
Functional Keywords | human antibody, riboflavin-binding, cofactor, multiple myeloma, igggar, immune system |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 8 |
Total formula weight | 185961.86 |
Authors | Zhu, X.,Wilson, I.A. (deposition date: 2006-01-05, release date: 2006-02-21, Last modification date: 2024-10-16) |
Primary citation | Zhu, X.,Wentworth, P.,Kyle, R.A.,Lerner, R.A.,Wilson, I.A. Cofactor-containing antibodies: Crystal structure of the original yellow antibody. Proc.Natl.Acad.Sci.Usa, 103:3581-3585, 2006 Cited by PubMed Abstract: Antibodies are generally thought to be a class of proteins that function without the use of cofactors. However, it is not widely appreciated that antibodies are believed to be the major carrier protein in human circulation for the important riboflavin cofactor that is involved in a host of biological phenomena. A further link between riboflavin and antibodies was discovered 30 years ago when a bright-yellow antibody, IgG(GAR), was purified from a patient with multiple myeloma who had turned yellow during the course of her disease. It was subsequently shown that the yellow color of this antibody was due to riboflavin binding. However, it was not known how and where riboflavin was bound to this antibody. We now report the crystal structure of this historically important IgG(GAR) Fab at 3.0-A resolution. The riboflavin is located in the antigen-combining site with its isoalloxazine ring stacked between the parallel aromatic moieties of TyrH33, PheH58, and TyrH100A. Together with additional hydrogen bonds, these interactions reveal the structural basis for high-affinity riboflavin binding. The ligand specificity of IgG(GAR) is compared with another riboflavin-binding antibody, IgG(DOT), which was purified from a second patient with multiple myeloma. The crystal structure of IgG(GAR) provides a starting point for attempts to understand the physiological relevance and chemical functions of cofactor-containing antibodies. PubMed: 16537445DOI: 10.1073/pnas.0600251103 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3 Å) |
Structure validation
Download full validation report
